News | January 10, 2025
Windlas Biotech’s new injectable facility receives GMP certification
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Fiscal 2024 total sales for the joint venture were approximately $190 million
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
Subscribe To Our Newsletter & Stay Updated
